Literature DB >> 10912643

The post-thrombotic syndrome.

E Bernardi1, P Prandoni.   

Abstract

One of every three patients with deep-vein thrombosis of the lower extremities will develop, within 5 years, post-thrombotic sequelae that vary from minor signs to severe manifestations such as chronic pain, intractable edema, and leg ulceration. The post-thrombotic syndrome (PTS) develops as a result of the combination of venous hypertension due to persistent outflow obstruction or valvular incompetence and abnormal microvasculature or lymphatic function. Among factors potentially related to the development of PTS, recurrent ipsilateral thrombosis plays a major role. Whether the extent and the location of the initial thrombosis are associated with the development of PTS is still controversial. The diagnosis of PTS can be accepted on clinical grounds for patients with a history of venous thrombosis. The combination of a standardized clinical evaluation with the results of compression ultrasonography and Doppler ultrasonography helps diagnose or exclude a previous proximal-vein thrombosis. Prevention of recurrent thrombosis and use of compression elastic stockings are the cornerstones of PTS prevention. The management of this condition is demanding and often frustrating. Although several surgical procedures have been tested, conservative treatment is largely preferable, as more than 50% of patients either remain stable or improve during long-term follow-up, if carefully supervised and instructed to wear proper elastic stockings. Clinical presentation helps predict the prognosis, being the outcome of patients who refer with initially severe manifestations more favorable than that of patients whose symptoms progressively deteriorate over time.

Entities:  

Mesh:

Year:  2000        PMID: 10912643     DOI: 10.1097/00063198-200007000-00015

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  8 in total

1.  Adipokines are associated with lower extremity venous disease: the San Diego population study.

Authors:  M A Allison; M Cushman; P W Callas; J O Denenberg; N E Jensky; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 3.  Total hip arthroplasty: areview of advances, advantages and limitations.

Authors:  Xin-Wei Liu; Ying Zi; Liang-Bi Xiang; Yu Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Incidence of postthrombotic syndrome in patients undergoing primary total hip arthroplasty for osteoarthritis.

Authors:  Steven J Fitzgerald; Christopher M McAndrew; Matthew J Kraay; Victor M Goldberg
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

Review 5.  Incidence and cost burden of post-thrombotic syndrome.

Authors:  Aneel A Ashrani; John A Heit
Journal:  J Thromb Thrombolysis       Date:  2009-02-18       Impact factor: 2.300

6.  A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children.

Authors:  Neil A Goldenberg; Janette D Durham; R Knapp-Clevenger; Marilyn J Manco-Johnson
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

7.  The causes of lower-extremity deep venous thrombosis in the children with cranial diseases.

Authors:  Yan Wang; Wei Liu; Ge Jia; Na Li; Yulong Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  Incidence of postthrombotic syndrome in patients undergoing primary total knee arthroplasty for osteoarthritis.

Authors:  Christopher M McAndrew; Steven J Fitzgerald; Matthew J Kraay; Victor M Goldberg
Journal:  Clin Orthop Relat Res       Date:  2009-06-19       Impact factor: 4.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.